AKYA: Akoya Biosciences, Inc. EV/EBITDA Multiple

Corporate emblem and logo of Akoya Biosciences, Inc. (AKYA)

Due to the neutral status of biomedicine, Akoya Biosciences (AKYA) operates within a stable geopolitical environment. The company's price chart reflects an EV/EBITDA metric of . The business relies on US-based system assembly and reagent production capacities. High barriers to entry are created by unique tissue analysis patents, which compel customers to use only original consumables.

Akoya - AKYA Enterprise Value to EBITDA Ratio (period 07/04/2022 - 11/13/2026)

Summary analytical data breakdowns for akoyabio.com (AKYA)

- stock price and consensus target price:
Stock Quotes Akoya Biosciences, Inc.|AKYA - Analyst Forecast Prices
- market capitalization information:
Market Capitalization AKYA|AKYA - Company Buyout Price
- issuer book value statistics:
Book Value per Share Akoya Biosciences|AKYA - Company Net Assets|Market Cap to Net Assets Ratio akoyabio.com|AKYA - Aggregate Asset Value
- company liabilities and liquidity data:
Debt to Equity Akoya Biosciences|AKYA - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Akoya Biosciences, Inc.|AKYA - Company Cumulative Debt|Debts to Book Capitalization AKYA|AKYA - Company Long-Term Indebtedness|Company Short-Term Debts Akoya Biosciences|Quick Ratio akoyabio.com
- financial results and valuation multiples details:
AKYA - Net Income|Projected Future Earnings Akoya Biosciences|AKYA - P/E Multiple|Future Price to Earnings Akoya Biosciences, Inc.|AKYA - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio AKYA|AKYA - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Akoya Biosciences|AKYA - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months akoyabio.com|AKYA - Net earnings per share change in current year|Expected earnings per share growth for next year Akoya Biosciences
Initial company analysis:Akoya AKYA
Original product of akoyabio.com

This multiple determines the total enterprise value, including debt, relative to its earnings before interest, taxes, depreciation, and amortization. By analyzing the EV/EBITDA value of the company on the chart, an investor assesses the asset's payback period, excluding the impact of debt load and accounting policies. For Akoya Biosciences (AKYA), this indicator is critical when evaluating capital-intensive developments in spatial biology and tissue imaging.

Competitor analysis for Akoya Biosciences

Abbott Laboratories Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio TMO (Thermo Scientific)|GE HealthCare - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio mt.com MTD|WAT: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Bio-Techne Corp|Enterprise Value to EBITDA Ratio BRKR|AZTA: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Varex Imaging (VREX)|Enterprise Value to EBITDA Ratio semlerscientific.com SMLR|EV/EBITDA Multiple BFLY (Butterfly Network)|Mesa Laboratories Inc (MLAB) - Company Value to EBITDA|Quantum-Si Corp - EV/EBITDA Multiple|NNOX (Nano-X Imaging Ltd) - Enterprise Value to Operating Income Before Depreciation|QTRX: EV/EBITDA Multiple|MASS - Total Company Value to Operating Income Before Depreciation Ratio|CV (CapsoVision, Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio MaxCyte Inc. (MXCT)|EV/EBITDA Multiple RPID|EV/EBITDA Multiple Seer Bio (SEER)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Hyperfine, Inc. HYPR|fonar.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|DXR: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation MDAI (spectral-ai.com)|VIVS: EV/EBITDA Multiple|Company Value to EBITDA Aclarion Corporation (ACON)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ThermoGenesis|TLIS - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio TTOO (T2 Biosystems)